NAYA Biosciences, Inc. Common Stock (IVF) Comparison with companies in other sectors?

NAYA Biosciences, Inc. Common Stock has a share price of 928.27K. You can analyze NAYA Biosciences, Inc. Common Stock (IVF) competitors across different market sectors through stock heatmaps.

What are IVF's NET and operating margins?

NAYA Biosciences, Inc. Common Stock (IVF) operating margin is around -3.68, and net profit margin is approximately -3.78 as of the latest reports.

In what way does IVF's earnings per share (EPS) trend reflect its financial momentum?

NAYA Biosciences, Inc. Common Stock (IVF) EPS is -105.51 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for NAYA Biosciences, Inc. Common Stock is -0.02, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for NAYA Biosciences, Inc. Common Stock?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for NAYA Biosciences, Inc. Common Stock like P/E which is -0.13, P/B which is 0.95, and PEG which is 0.004. Compare them with sector averages to evaluate if the stock is priced fairly.

NAYA Biosciences, Inc. Common Stock

IVF•NASDAQ

Healthcare

Medical - Healthcare Plans

$2.24

$0.05(2.28%)

Fundamental Analysis of NAYA Biosciences, Inc. Common Stock (IVF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-105.51

P/E Ratio

-0.02

ROE

-5.72%

Net Margin

-3.78%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.08M

Shares OutstandingTotal number of shares issued

$928.27K

Book Value/ShareNet worth per share

$2.40

Revenue/ShareAnnual revenue per share

$4.75

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-105.51

Net MarginNet income as percentage of revenue

-377.72%

Operating MarginOperating income as percentage of revenue

-368.37%

ROEReturn on shareholders' equity

-571.72%

ROAReturn on total assets

-78.45%

ROCEReturn on capital employed

-186.46%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-4.61

Cash/ShareCash and equivalents per share

$0.60

FCF YieldFree cash flow as percentage of market cap

-304.06%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for IVFFinancial Ratios Analysis details for IVF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for IVFSector Benchmarking details for IVF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for NAYA Biosciences, Inc. Common Stock Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of NAYA Biosciences, Inc. Common Stock. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account NAYA Biosciences, Inc. Common Stock's unique business strengths and challenges.

Key Financial Metrics for NAYA Biosciences, Inc. Common Stock

For NAYA Biosciences, Inc. Common Stock, essential financial indicators include EPS -105.51, PE -0.02, and ROE -5.72. These key ratios reveal insights into NAYA Biosciences, Inc. Common Stock's profitability, valuation, and operational health. Understanding these metrics enables you to compare NAYA Biosciences, Inc. Common Stock with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of NAYA Biosciences, Inc. Common Stock

Metrics like Net Margin -377.72% and ROA -78.45% shed light on how well NAYA Biosciences, Inc. Common Stock is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether NAYA Biosciences, Inc. Common Stock can sustain its operations and continue growing in the future.

Valuation and Market Position of NAYA Biosciences, Inc. Common Stock

Using ratios such as P/B Ratio 0.95 and PEG Ratio 0.004, investors can assess whether NAYA Biosciences, Inc. Common Stock is appropriately valued based on its financials and growth potential. These figures, combined with NAYA Biosciences, Inc. Common Stock's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for NAYA Biosciences, Inc. Common Stock

Financial health indicators, such as Debt/Equity Ratio 2.65 and Cash Flow $-4.61, provide a snapshot of NAYA Biosciences, Inc. Common Stock's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like NAYA Biosciences, Inc. Common Stock, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for NAYA Biosciences, Inc. Common Stock

Investing in NAYA Biosciences, Inc. Common Stock based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at NAYA Biosciences, Inc. Common Stock focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;